Delivery Order SPE2DR25D1202-SPE2DR26F71TP
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,064.07 to AmerisourceBergen Drug Corp for the supply of Savella 50 mg tablets (60-count units) on August 4, 2025, with completion expected by August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will be delivered to the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $18,324.20 to AmerisourceBergen Drug Corp for the supply of Savella (milnacipran) 100 mg tablets in quantities of 60 units. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,237.86 to AmerisourceBergen Drug Corp for Savella 100 mg tablets (60-count units) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. Savella (milnacipran) is a serotonin-norepinephrine reuptake inhibitor indicated for fibromyalgia...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Savella 50 mg tablets (60-count units) under a firm fixed-price contract. The order, valued at $1,412.55, is set to be completed by August 25, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This delivery order represents a non-set-aside, competitively awarded procurement and serves as a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,094.34 to AmerisourceBergen Drug Corp for the supply of Savella (milnacipran) 50 mg tablets in a quantity of 60 units. This contract, designated as a firm fixed price delivery order, was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025. The award represents a non-competitive, non-set-aside transaction and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,580.37 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Savella (milnacipran) 50 mg tablets in a 60-count quantity. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, represents a competitively awarded, non-set-aside contract for pharmaceutical procurement. The medication will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $1,092.15 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Savella 50 mg tablets (60-count packages). This firm fixed-price, non-set-aside contract will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA....
- The Defense Logistics Agency awarded a delivery order valued at $3,321.20 to AmerisourceBergen Drug Corp for 60 tablets of Savella 12.5 mg on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Savella (milnacipran) is a serotonin-norepinephrine reuptake inhibitor used primarily for fibromyalgia...
- This delivery order, issued by the Defense Logistics Agency (DLA), awards AmerisourceBergen Drug Corp a $6.38K contract for Savella 100 mg tablets (60-count units) with a completion date of August 12, 2025. The contract, which was competitively awarded with no set-aside designation, utilizes firm fixed pricing and represents a direct pharmaceutical supply fulfillment under DLA's medical procurement framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Savella 100 mg tablets (60-count units) with a ceiling value of $4,750.50. This firm fixed-price delivery order, with an ultimate completion date of August 4, 2025, represents a non-set-aside competitive award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Savella (milnacipran) is a serotonin-norepinephrine reuptake inhibitor...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F71TPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,152.26 to AmerisourceBergen Drug Corp for the supply of Savella 25 mg tablets (60-count) on October 29, 2025, with an ultimate completion date of October 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order exemplifies the operational scope of AmerisourceBergen's comprehensive IDC with DLA, which serves as a global pharmaceutical support vehicle supplying the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Savella (milnacipran) is a neurological treatment commonly prescribed for fibromyalgia pain management within military healthcare systems. The prime IDC enables AmerisourceBergen to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices, supporting military healthcare programs worldwide with the flexibility to issue individual delivery orders for specific medical commodities as needed.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 10/29/25 |